spacer
home > epc > summer 2002 > drug delivery technologies: innovations and market challenges - a report in the biotechnology reports series
PUBLICATIONS
European Pharmaceutical Contractor

Drug Delivery Technologies: Innovations and Market Challenges - A Report in The Biotechnology Reports Series

The drug delivery industry has been something of a Cinderella until recently. It is clearly appropriate that as the biotechnology industry becomes more prominent as a source of medicines - albeit typically macromolecules rather than the smaller, organic molecules of the traditional, mainstream pharmaceutical industry - this report should issue in the Biotechnology Reports series. Nevertheless, this report does pay major attention to smaller sized pharmaceutical molecules. The information contained within it is not of a highly technical nature. However, there are already many publications meeting the needs of the pharmaceutical scientist active in the area. This report addresses the non-technical needs of this and other audiences.

An introductory chapter makes the case for the importance of drug delivery in the development of both novel compounds and established products. The various advantages of drug delivery technologies are delineated, as are the various barriers which drug delivery technologies seek to address. A useful discussion of how pharmaceutical and biotechnological industry dynamics are underpinning a growth rate of 15 to 20 per cent per year in the drug delivery industry, is enhanced by useful examples such as patent extension strategies for Eli Lilly with Prozac and AstraZeneca with Losec.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
A review by Dr Roy Drucker, General Manager of Technomark Consulting Services Limited

Roy Drucker joined the European R&D arm of Sterling Drug Inc as a Medical Advisor. He was promoted to being responsible for clinical pharmacology, drug metabolism and bioanalysis in Europe. In 1986 he moved to the Upjohn Company, subsequently Pharmacia & Upjohn, Inc., where he held a range of international responsibilities. His positions there included Director of Marketing with responsibility for worldwide marketing of cardiovascular products; Executive Director, European Community Affairs and Business Systems; and Vice-President, Drug Development, with global responsibility in multiple therapeutic areas for clinical drug development and medical support for marketed products.

A graduate of the Harvard Business School Advanced Management Program, a member of the Securities Institute and an FSA registered Approved Person, Roy has been based in Belgium, the UK, and the US. He has been General Manager of Technomark since September 1996.

spacer
Roy Drucker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Mr Turhan Ozen Chief Cargo Officer at Turkish Airlines elected to the International Air Cargo Association (TIACA) Committee

Turhan Ozen, serving as Chief Cargo Officer at the global brand Turkish Airlines, was elected to the International Air Cargo Association (TIACA) Committee, the joint voice of the industry that aims to enhance the air cargo profile with intensive efforts towards the global standards.
More info >>

White Papers

Syringe siliconization

Gerresheimer AG

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Irelandís premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement